Legal & General Group
PALI icon

Legal & General Group’s Palisade Bio PALI Stock Holding History

Legal & General Group’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.9K Buy
+14,323
New +$28.2K ﹤0.01% 2953

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Legal & General Group's PALI Position: Q2 2026 in Review

Legal & General Group opened a new position in Palisade Bio (PALI) in Q2 2026: 14,323 shares worth $29.9K. The stake represents ﹤0.01% of the portfolio and ranks #2953 among its holdings.

124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Legal & General Group held 14,323 shares of Palisade Bio worth $29.9K as of Q2 2026.
  • Palisade Bio was a new Legal & General Group position in Q2 2026.
  • Palisade Bio made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2953 holding.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.